Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
NNOX 
Nano X Imaging Ltd (NNOX)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/03/2025: NNOX (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
4 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $8.75
1 Year Target Price $8.75
| 4 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -13.76% | Avg. Invested days 40 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 07/03/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 339.52M USD | Price to earnings Ratio - | 1Y Target Price 8.75 |
Price to earnings Ratio - | 1Y Target Price 8.75 | ||
Volume (30-day avg) 4 | Beta 1.98 | 52 Weeks Range 3.75 - 11.00 | Updated Date 07/4/2025 |
52 Weeks Range 3.75 - 11.00 | Updated Date 07/4/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.91 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -500.53% |
Management Effectiveness
Return on Assets (TTM) -17.89% | Return on Equity (TTM) -30.11% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 284454984 | Price to Sales(TTM) 29.41 |
Enterprise Value 284454984 | Price to Sales(TTM) 29.41 | ||
Enterprise Value to Revenue 24.64 | Enterprise Value to EBITDA -7.41 | Shares Outstanding 63819200 | Shares Floating 61043036 |
Shares Outstanding 63819200 | Shares Floating 61043036 | ||
Percent Insiders 0.23 | Percent Institutions 24.7 |
Upturn AI SWOT
Nano X Imaging Ltd
Company Overview
History and Background
Nano X Imaging Ltd. (Nanox) was founded in 2012. It aims to revolutionize medical imaging by developing a more accessible and affordable digital X-ray technology.
Core Business Areas
- Medical Imaging Systems: Develops, manufactures, and commercializes the Nanox.ARC digital X-ray source-based imaging system. This includes hardware and software solutions for medical imaging.
- Cloud Services: Offers cloud-based services (Nanox.CLOUD) for image storage, analysis, and reporting, facilitating remote diagnostics and consultations.
- Pay-Per-Scan: Business model offering medical scanning services to clinics and hospitals on a pay-per-scan basis.
Leadership and Structure
The company's leadership team includes Erez Meltzer (Chief Executive Officer) and Ran Poliakine (Chairman). The organizational structure is designed to support research, development, manufacturing, and commercialization efforts.
Top Products and Market Share
Key Offerings
- Nanox.ARC: A novel digital X-ray source that aims to provide a more affordable and accessible medical imaging solution. Nanox does not have significant market share due to the unproven nature of their technology and regulatory hurdles. Competitors include GE Healthcare (GE), Siemens Healthineers (SIEGY), and Philips (PHG).
- Nanox.CLOUD: A cloud-based platform for image storage, analysis, and reporting. Revenue from this product is currently minimal. Competitors include AWS (AMZN), Google Cloud (GOOGL), and Microsoft Azure (MSFT) with their respective healthcare solutions.
Market Dynamics
Industry Overview
The medical imaging market is a large and established industry, dominated by large players offering a variety of imaging modalities like X-ray, MRI, CT, and Ultrasound. The market is growing due to increasing demand for diagnostic imaging services.
Positioning
Nanox aims to disrupt the traditional X-ray market with its potentially lower-cost and more accessible technology. It positions itself as an innovator focused on expanding access to medical imaging, particularly in underserved communities.
Total Addressable Market (TAM)
The global medical imaging market is expected to reach hundreds of billions of dollars. Nanox's TAM is focused on the X-ray segment and emerging markets where affordability is a key barrier. Its current positioning is relatively small compared to the total addressable market, as they are an emerging player.
Upturn SWOT Analysis
Strengths
- Innovative digital X-ray source technology
- Potential for lower manufacturing costs
- Cloud-based service platform (Nanox.CLOUD)
- Pay-per-scan business model
Weaknesses
- Unproven technology with limited real-world data
- Regulatory approvals required for commercialization
- Dependence on successful manufacturing and distribution
- Negative media coverage and allegations of misleading claims.
Opportunities
- Expanding access to medical imaging in underserved markets
- Partnerships with healthcare providers and distributors
- Development of new imaging applications
- Integration with AI-powered diagnostic tools
Threats
- Competition from established medical imaging companies
- Technological advancements by competitors
- Regulatory hurdles and delays
- Negative publicity and reputational risk
- Difficulties in achieving profitability
Competitors and Market Share
Key Competitors
- GE
- SIEGY
- PHG
Competitive Landscape
Nanox faces significant competition from established medical imaging companies with extensive resources, established customer relationships, and proven technologies. Nanox's success depends on its ability to demonstrate the superiority and cost-effectiveness of its technology.
Growth Trajectory and Initiatives
Historical Growth: Historical growth is negligible, as the company is in the pre-commercialization phase.
Future Projections: Future projections are highly uncertain and depend on achieving regulatory approvals, successful manufacturing, and market acceptance of its technology. Analyst estimates vary widely.
Recent Initiatives: Recent initiatives include seeking regulatory approvals (FDA), securing manufacturing partnerships, and expanding its geographic reach.
Summary
Nanox aims to disrupt the medical imaging market with its novel X-ray technology. The company faces regulatory hurdles and intense competition. Success depends on commercialization, market acceptance, and profitability. Nanox's pay-per-scan business model has promise in theory, but its unproven technology makes its future viability uncertain.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company reports
- Analyst estimates
- Industry publications
- Financial news sources
Disclaimers:
The data and analysis provided are for informational purposes only and should not be considered investment advice. Market share data is approximate and may vary based on source. The information is based on currently available data and may change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Nano X Imaging Ltd
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2020-08-21 | CEO & Acting Chairman of the Board Mr. Erez I. Meltzer | ||
Sector Healthcare | Industry Medical Devices | Full time employees 165 | Website https://www.nanox.vision |
Full time employees 165 | Website https://www.nanox.vision | ||
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide and obtain remote interpretations of imaging data; Nanox.CONNECT to receive local regulatory approvals and explore and evaluate the business model and the potential service; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers and mobile imaging service providers, urgent care facilities, and multi-specialty physician groups. The company was founded in 2011 and is headquartered in Petah Tikva, Israel.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.